Researchers have used Artificial Intelligence (AI) to train algorithms and predict tumour sensitivity in three advanced non-small cell lung cancer therapies which can help predict more accurate treatment efficacy at an early stage of the disease. The researchers at Columbia University’s Irving Medical Center analysed CT images from 92 patients receiving drug agent Nivolumab in two trials; 50 patients receiving Docetaxel in one trial, and 46 patients receiving Gefitinib in one trial.
L’Intelligenza Artificiale per migliorare lo sviluppo di un test diagnostico.
L’Intelligenza Artificiale per ottimizzare un test diagnostico Le aziende che investono fortemente in ricerca e tool diagnostici di frontiera hanno grande interesse a proporre kit